High Power Short Duration Ablation Compared to Moderate Power Long Duration Ablation for Pulmonary Vein Isolation

High Power Short Duration Ablation Compared to Moderate Power Long Duration Ablation for Pulmonary Vein Isolation: Safety and Acute Procedural Outcome

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05959798

Enrollment

204

Registered

2023-07-25

Start date

2019-04-20

Completion date

2023-07-17

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paroxysmal Atrial Fibrillation

Brief summary

High Power Short Duration Ablation Compared to Moderate Power Long Duration Ablation for Pulmonary Vein Isolation: safety and acute procedural outcome

Interventions

PROCEDUREHigh power short duration ablation

Pulmonary vein isolation by high power short duration radiofrequency catheter ablation

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Inclusion criteria

* symptomatic, documented, drug-resistent paroxysmal atrial fibrillation * effective oral anticoagulation

Exclusion criteria

* any prior left atrial ablation procedure * presence of left atrial thrombus * secondary atrial fibrillation due to electrolyte imbalance or thyroid disease * any prior oesophageal or gastric surgery

Design outcomes

Primary

Measure	Time frame
Number of reconnected pulmonary veins 20 minutes after ablation in comparison of both ablation groups	Acute endpoint

Secondary

Measure	Time frame
Time to first documented recurrence of atrial fibrillation after a 6-week blanking period.	12 months after ablation

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026